[Therapy of cardiac insufficiency with diuretics].
D000584:Amiloride / Q000627:therapeutic use; D001581:Benzothiadiazines; D001786:Blood Glucose / Q000032:analysis; D004232:Diuretics / Q000009:adverse effects / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005260:Female; D005665:Furosemide / Q000627:therapeutic use; D006177:Gynecomastia / Q000139:chemically induced; D006333:Heart Failure / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D007008:Hypokalemia / Q000139:chemically induced; D007674:Kidney Diseases / Q000188:drug therapy; D008297:Male; D011188:Potassium / Q000378:metabolism; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use; D013148:Spironolactone / Q000009:adverse effects; D014223:Triamterene / Q000627:therapeutic use; D014527:Uric Acid / Q000097:blood
D001581:Benzothiadiazines; D001786:Blood Glucose; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; D014527:Uric Acid; D013148:Spironolactone; D000584:Amiloride; D005665:Furosemide; D011188:Potassium; D014223:Triamterene
Therapie der Herzinsuffizienz mit Diuretika.